Form 8-K - Current report:
SEC Accession No. 0000879169-26-000016
Filing Date
2026-03-26
Accepted
2026-03-26 08:38:39
Documents
13
Period of Report
2026-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K incy-20260325.htm   iXBRL 8-K 25502
2 EX-99.1 march2026titlechanges-ex991.htm EX-99.1 10350
6 incy-20220802xex99d1001a.jpg GRAPHIC 8537
  Complete submission text file 0000879169-26-000016.txt   165822

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT incy-20260325.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT incy-20260325_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT incy-20260325_pre.xml EX-101.PRE 12506
16 EXTRACTED XBRL INSTANCE DOCUMENT incy-20260325_htm.xml XML 2715
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Filer) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12400 | Film No.: 26794487
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)